Hypoxia promotes tumor growth in linking angiogenesis to immune escape

Cited by papers we hold 8

• Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers · 2023
  No notice
• Monocyte-endothelial cell interactions in vascular and tissue remodeling · 2023
  No notice
• Direct and Indirect Modulation of T Cells by VEGF-A Counteracted by Anti-Angiogenic Treatment · 2021
  No notice
• Scientific Rationale for Combined Immunotherapy with PD-1/PD-L1 Antibodies and VEGF Inhibitors in Advanced Hepatocellular Carcinoma · 2020
  No notice
• Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC) · 2020
  No notice
• Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges · 2019
  No notice
• Impact of Metabolism in on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment · 2017
  No notice
• Control of the Immune Response by Pro-Angiogenic Factors · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.